PortfoliosLab logoPortfoliosLab logo
SURG vs. SPOK
Performance
Return for Risk
Drawdowns
Volatility
Dividends
Financials

Performance

SURG vs. SPOK - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in SurgePays, Inc. (SURG) and Spok Holdings, Inc. (SPOK). The values are adjusted to include any dividend payments, if applicable.

Loading charts...

Returns By Period

In the year-to-date period, SURG achieves a -68.53% return, which is significantly lower than SPOK's -15.10% return.


SURG

1D
-5.57%
1M
-7.02%
YTD
-68.53%
6M
-69.97%
1Y
-82.12%
3Y*
-58.84%
5Y*
-42.05%
10Y*

SPOK

1D
-3.29%
1M
1.12%
YTD
-15.10%
6M
-14.65%
1Y
-27.45%
3Y*
4.01%
5Y*
9.05%
10Y*
2.05%
*Multi-year figures are annualized to reflect compound growth (CAGR)

SURG vs. SPOK - Yearly Performance Comparison


2026 (YTD)20252024202320222021202020192018
SURG
SurgePays, Inc.
-68.53%-6.18%-72.40%-1.68%224.75%-65.62%-60.83%-21.05%-69.84%
SPOK
Spok Holdings, Inc.
-15.10%-10.96%12.06%107.98%2.88%-11.89%-4.22%-4.21%-10.37%

Correlation

The correlation between SURG and SPOK is 0.11, which is low. Their price movements are largely independent, making them effective diversification partners.


Correlation
Correlation (1Y)
Calculated over the trailing 1-year period

0.11

Correlation (3Y)
Calculated over the trailing 3-year period

0.23

Correlation (5Y)
Calculated over the trailing 5-year period

0.16

Correlation (All Time)
Calculated using the full available price history since Jan 17, 2018

0.11

The correlation between SURG and SPOK shifts across timeframes, from 0.11 (all time) to 0.23 (3 years), reflecting how their relationship changes across market environments.

Fundamentals

EPS

SURG:

-$2.12

SPOK:

$0.60

PS Ratio

SURG:

0.21

SPOK:

1.63

Total Revenue (TTM)

SURG:

$50.37M

SPOK:

$136.64M

Gross Profit (TTM)

SURG:

-$19.42M

SPOK:

$113.27M

EBITDA (TTM)

SURG:

-$40.48M

SPOK:

$21.05M

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Return for Risk

SURG vs. SPOK — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

SURG
SURG Risk / Return Rank: 55
Overall Rank
SURG Sharpe Ratio Rank: 77
Sharpe Ratio Rank
SURG Sortino Ratio Rank: 44
Sortino Ratio Rank
SURG Omega Ratio Rank: 44
Omega Ratio Rank
SURG Calmar Ratio Rank: 33
Calmar Ratio Rank
SURG Martin Ratio Rank: 55
Martin Ratio Rank

SPOK
SPOK Risk / Return Rank: 1111
Overall Rank
SPOK Sharpe Ratio Rank: 66
Sharpe Ratio Rank
SPOK Sortino Ratio Rank: 1010
Sortino Ratio Rank
SPOK Omega Ratio Rank: 88
Omega Ratio Rank
SPOK Calmar Ratio Rank: 1515
Calmar Ratio Rank
SPOK Martin Ratio Rank: 1717
Martin Ratio Rank
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

SURG vs. SPOK - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for SurgePays, Inc. (SURG) and Spok Holdings, Inc. (SPOK). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


SURGSPOKDifference

Sharpe ratio

Return per unit of total volatility

-0.87

-0.93

+0.06

Sortino ratio

Return per unit of downside risk

-1.65

-1.11

-0.54

Omega ratio

Gain probability vs. loss probability

0.77

0.83

-0.07

Calmar ratio

Return relative to maximum drawdown

-0.96

-0.69

-0.27

Martin ratio

Return relative to average drawdown

-1.55

-1.13

-0.42

SURG vs. SPOK - Sharpe Ratio Comparison

The current SURG Sharpe Ratio is -0.87, which is comparable to the SPOK Sharpe Ratio of -0.93. The chart below compares the historical Sharpe Ratios of SURG and SPOK, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.


Loading charts...

Sharpe Ratios by Period


SURGSPOKDifference

Sharpe Ratio (1Y)

Calculated over the trailing 1-year period

-0.87

-0.93

+0.06

Sharpe Ratio (5Y)

Calculated over the trailing 5-year period

-0.44

0.27

-0.71

Sharpe Ratio (10Y)

Calculated over the trailing 10-year period

0.06

Sharpe Ratio (All Time)

Calculated using the full available price history

-0.41

0.07

-0.48

Drawdowns

SURG vs. SPOK - Drawdown Comparison

The maximum SURG drawdown since its inception was -99.21%, which is greater than SPOK's maximum drawdown of -73.90%. Use the drawdown chart below to compare losses from any high point for SURG and SPOK.


Loading charts...

Drawdown Indicators


SURGSPOKDifference

Max Drawdown

Largest peak-to-trough decline

-99.21%

-73.90%

-25.31%

Max Drawdown (1Y)

Largest decline over 1 year

-85.42%

-39.88%

-45.54%

Max Drawdown (3Y)

Largest decline over 3 years

-94.42%

-39.88%

-54.54%

Max Drawdown (5Y)

Largest decline over 5 years

-94.42%

-39.88%

-54.54%

Max Drawdown (10Y)

Largest decline over 10 years

-62.99%

Current Drawdown

Current decline from peak

-99.17%

-37.82%

-61.35%

Average Drawdown

Average peak-to-trough decline

-85.39%

-28.09%

-57.30%

Ulcer Index

Depth and duration of drawdowns from previous peaks

52.80%

24.28%

+28.52%

Volatility

SURG vs. SPOK - Volatility Comparison

SurgePays, Inc. (SURG) has a higher volatility of 20.45% compared to Spok Holdings, Inc. (SPOK) at 6.60%. This indicates that SURG's price experiences larger fluctuations and is considered to be riskier than SPOK based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


Loading charts...

Volatility by Period


SURGSPOKDifference

Volatility (1M)

Calculated over the trailing 1-month period

20.45%

6.60%

+13.85%

Volatility (6M)

Calculated over the trailing 6-month period

86.55%

20.91%

+65.64%

Volatility (1Y)

Calculated over the trailing 1-year period

94.05%

29.53%

+64.52%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

95.83%

34.11%

+61.72%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

107.67%

36.28%

+71.39%

Dividends

SURG vs. SPOK - Dividend Comparison

SURG has not paid dividends to shareholders, while SPOK's dividend yield for the trailing twelve months is around 11.80%.


PositionTTM20252024202320222021202020192018201720162015
SPOK
Spok Holdings, Inc.
11.80%9.48%7.79%8.07%15.26%5.36%4.49%4.09%3.77%3.19%3.61%3.41%
SURG
SurgePays, Inc.
0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%

Financials

SURG vs. SPOK - Financials Comparison

This section allows you to compare key financial metrics between SurgePays, Inc. and Spok Holdings, Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


0.0010.00M20.00M30.00M40.00M20222023202420252026
18.68M
33.23M
(SURG) Total Revenue
(SPOK) Total Revenue
Values in USD except per share items

Frequently Asked Questions


SURG and SPOK have a correlation of 0.11, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

SURG has higher volatility (20.45%) compared to SPOK (6.60%). In terms of maximum drawdown, SURG dropped -99.21% vs SPOK's -73.90%.

SURG currently has the higher Sharpe Ratio (-0.87 vs -0.93), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.

Portfolio Optimizer

Find the right allocation for SURG and SPOK

Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.

Open Portfolio Optimizer